This article serves as a formal correction to the protocol "SHERLOCK: nucleic acid detection with CRISPR nucleases," originally published in Nature Protocols. While the SHERLOCK (Specific High-sensitivity Enzymatic Reporter UnLOCKing) platform remains a cornerstone of CRISPR-based diagnostics, this amendment provides essential updates to the reported sensitivity limits of key Cas13 enzymes and rectifies typographical errors within the original text.
The Importance of Precise Sensitivity Benchmarks
The SHERLOCK protocol was developed to provide a portable, ultra-sensitive, and highly specific method for nucleic acid detection, bridging the gap between laboratory-bound gold standards like qPCR and the urgent need for rapid field diagnostics. The system relies on a multi-step biochemical process: isothermal amplification (RPA or LAMP), transcription (for DNA targets), and CRISPR-mediated detection.
In the detection phase, a Cas13 or Cas12 enzyme, guided by a specific crRNA, binds to its target. This binding triggers "collateral" cleavage activity, where the enzyme indiscriminately cuts nearby fluorescently labeled reporter molecules. Because the sensitivity of these enzymes determines the detection floor of the entire assay, accurate reporting of these values is critical for experimental reproducibility and the prevention of false negatives in clinical or environmental settings.
Revised Sensitivity Values for Cas13 Variants
Following a review of the original data, it was determined that the sensitivity values for three Cas13 orthologs were reported incorrectly in the original publication. The corrected values, which should replace those previously listed in Box 1 of the protocol, are as follows:
- LwaCas13a: The corrected sensitivity is $5 \times 10^7$ aM (previously reported as $\sim 5 \times 10^5$ aM).
- CcaCas13b: The corrected sensitivity is $\sim 5 \times 10^7$ aM (previously reported as $\sim 5 \times 10^6$ aM).
- PsmCas13b: The corrected sensitivity is $\sim 5 \times 10^9$ aM (previously reported as $\sim 5 \times 10^8$ aM).
These revisions represent a shift of one to two orders of magnitude. While the SHERLOCK system remains highly effective, these updated benchmarks provide a more realistic performance ceiling for researchers when using these specific enzymes without additional pre-amplification optimizations.
Clarification of Visual Documentation
In addition to the biochemical data, this correction addresses a typographical error in the "Anticipated Results" section of the original protocol. The text previously included a reference to a "Figure 1d"; however, Figure 1 only contains panels (a) through (c). This correction ensures that the narrative flow of the protocol aligns accurately with the provided visual data.
Implications for Future Research
These updates do not alter the fundamental methodology of the SHERLOCK platform but do emphasize the necessity of rigorous validation when transitioning molecular tools from proof-of-concept to standardized protocols. For researchers targeting extremely low-abundance sequences, these revised values suggest a greater reliance on the efficiency of pre-amplification steps or the exploration of newer, more sensitive Cas variants. This correction ensures that the scientific community has the most accurate baseline for developing next-generation diagnostic tools.
Summary updated